Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.09.14
关于使用部分超募资金增补永世性流动资金的通告
2010.08.04
关于网下配售股份上市流通的提醒性通告
2010.07.31
2010年半年度财务报告
2010.07.28
关于完成工商变换挂号的通告
2010.07.06
2010年第二次暂时股东大会决议通告
2010.07.06
2010年第二次暂时股东大会的执法意见书
2010.07.06
2010第二次暂时股东大会决议
2010.06.19
会计师事务所选聘制度(2010年6月)
2010.06.19
关于高级治理职员聘用和告退的通告
2010.06.19
中国建银投资证券有限责任公司关于公司2010年过活常关联生意的核查意见
第一页
上一页
144
145
146
147
148
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】